Your browser doesn't support javascript.
loading
Population pharmacokinetic simulation of varied Immune Globulin Subcutaneous (Human), 20% solution (Ig20Gly) loading and maintenance dosing regimens in immunoglobulin-naïve patients with primary immunodeficiency diseases.
Li, Zhaoyang; Dumas, Todd; Seth Berry, N; McCoy, Barbara; Yel, Leman.
Affiliation
  • Li Z; Takeda Development Center Americas, Inc, Cambridge, MA, USA. Electronic address: zhaoyang.li@takeda.com.
  • Dumas T; IQVIA, Overland Park, KS, USA. Electronic address: Todd.Dumas@quintiles.com.
  • Seth Berry N; IQVIA, Overland Park, KS, USA. Electronic address: Seth.Berry@quintiles.com.
  • McCoy B; Baxalta Innovations GmbH, a Takeda Company, Vienna, Austria. Electronic address: Barbara.McCoy@takeda.com.
  • Yel L; Takeda Development Center Americas, Inc, Cambridge, MA, USA. Electronic address: Leman.Yel@takeda.com.
Int Immunopharmacol ; 100: 108044, 2021 Nov.
Article in En | MEDLINE | ID: mdl-34601202

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Primary Immunodeficiency Diseases / Immunologic Factors / Models, Biological Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Int Immunopharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Year: 2021 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Primary Immunodeficiency Diseases / Immunologic Factors / Models, Biological Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Int Immunopharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Year: 2021 Document type: Article Country of publication: